Show simple item record

dc.contributor.authorFreeman, B.
dc.contributor.authorMacKenzie, R.
dc.contributor.authorDaube, Mike
dc.date.accessioned2017-06-23T03:00:10Z
dc.date.available2017-06-23T03:00:10Z
dc.date.created2017-06-19T03:39:44Z
dc.date.issued2017
dc.identifier.citationFreeman, B. and MacKenzie, R. and Daube, M. 2017. Should tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy? Public Health Research & Practise. 27 (2): e2721714.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/53474
dc.identifier.doi10.17061/phrp2721714
dc.description.abstract

Formation of Australia's National Drug Strategy (NDS) included an extensive consultation process that was open not only to community and public health stakeholders, but also to representatives of the tobacco and alcohol industries. Australia is bound by the World Health Organization Framework Convention on Tobacco Control, which requires governments to protect tobacco control measures from interference by the tobacco industry. NDS consultation submissions made by these conflicted industries are not publicly available for scrutiny. The NDS goals are at odds with the commercial agenda of industries that support regulatory stagnation, oppose and undermine effective action, ignore and distort evidence, and prioritise profits over health.

dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.titleShould tobacco and alcohol companies be allowed to influence Australia's National Drug Strategy?
dc.typeJournal Article
dcterms.source.volume27
dcterms.source.number2
dcterms.source.issn2204-2091
dcterms.source.titlePublic Health Res Pract
curtin.departmentPublic Health Advocacy Institute of WA
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/